0      0

National Symposium 2014

101 - The Changing Faces of Nephropathic Cystinosis: Clinical Challenges and Emerging Opportunities


‐ Apr 13, 2014 12:00pm

Standard: $ 20.00
Members: $ 0.00
Contact hours available until 4/16/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure:

Planning disclosures:
Barbara Monaghan discloses that she receives other financial/material support as owner of Cornerstone Medical Communications.
Patricia Wasserman discloses that she receives other financial/material support as owner of Cornerstone Medical Communications.

Speaker disclosures:
Ewa Elenberg discloses that she has received grant/research support from Raptor Therapeutics Inc., that she is a consultant/speaker’s bureau member for Raptor Pharmaceuticals, and that she is on the advisory board for Raptor Pharmaceuticals.
Paul Grimm receives research/grant support as Stanford primary investigator in studies of cystinosis and Procysbi in patients. Dr. Grimm also discloses that he is a member of the advisory board to Raptor Pharmaceuticals.
Ivette Jones discloses that she is is a member of the Raptor Pharmaceuticals Speaker's Bureau.

Planning Committee:
• Annette Hood discloses that she is a member of the Amgen speakers’ bureau.
• Denise Murcek discloses other financial/material support as an employee of the VA Medical Center.
• Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care.
• Kyra Trappett discloses other financial/material support as an employee of DaVita.

Commercial Support and Sponsorship:
Supported by an educational grant from Raptor Pharmaceuticals

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:
• Delineate pathological features of cystinosis.
• Identify infants and children at increased risk for the disease.
• Recognize early signs and symptoms as well as clinical manifestations of complications in young adults.

You must be logged in and own this session in order to post comments.

JIHYE JEONG
12/8/19 12:37 am

goood